JPM 2026 INNOVATION X HEALTH SUMMIT

This year’s theme, From Scarcity to Plenty: The Next Leap in Intelligent Health, explores how healthcare can move from systems defined by constraint to ecosystems powered by abundance—abundance of intelligence, automation, and participation—shaping a future where capacity expands, insight deepens, and patients become true partners in care.

• Kamal Jethwani, Founding partner and CEO, Decimal.health

This session frames why this moment is unmatched in its significance. Healthcare remains one of the world’s largest industries still running on outdated infrastructure, even as breakthroughs in intelligence, biology, and connectivity reach maturity. It is a rare convergence point—one that offers a narrow window to redefine the system’s architecture for the decades ahead.

• David Rhew, M.D, Global Chief Medical Officer & VP of Healthcare, Microsoft

This conversation brings together an investor known for backing category-defining founders and a health system leader shaping real-world transformation. Their combined perspectives—one seeing where intelligent health is heading, the other navigating its on-the-ground realities—will set the tone with the clarity, urgency, and ambition needed.

• Chima Otsuka, Senior Venture Partner, Suncoast Ventures
• Megan Scheffel, Head of Healthcare and Life Science Lending, Silicon Valley Bank (Moderator)

This session explores what healthcare looks like when intelligence shifts from being an application to becoming the underlying operating fabric. It examines how real-time insight, scalable digital infrastructure, and human-centered design can enable systems that anticipate needs, reduce friction, and deliver care in more adaptive and equitable ways.

• Amy McDonough, Managing Director, Google for Health
• Inga T. Lennes MD, MPH, MBA, President, Faculty Practice Organization & SVP, Ambulatory Services, UCSF Health
• Diana Gelston, President and Managing Partner, Decimal.health (Moderator)

This session explores what healthcare can become when intelligence shifts from a tool to the foundational operating layer of care. Bringing together a leading health system and a major technology innovator, the conversation will examine how AI, data, and scalable digital infrastructure are being translated into real-world solutions that meet people where they are. Their combined perspectives will illuminate how systems can evolve into more adaptive, proactive, and human-centered models of care.

• Jenn Bonilla, Vice President - Portfolio Strategy, Moffitt Cancer Center
• Kamal Jethwani, Founding partner and CEO, Decimal.health (Moderator)

As demand increases and the workforce tightens, healthcare’s existing access models can no longer support the needs of patients or providers. This session brings together leaders who are redefining what “access” means—designing care models that reach patients where they are, expanding system capacity through redesigned workflows, team-based approaches, and intelligent tools, and reimagining the front door of healthcare to be more responsive, equitable, and sustainable for the future.

Hosted by HIMSS NorCal Chapter

• Nisha Gandhi, VP, Venture Growth & Marketing, AccelerOnc Studio (Moderator)

In a landscape focused on efficiency and transformation, the most meaningful return on innovation is time—time restored to clinicians, patients, and operations. This investor-focused discussion examines why time has become the ultimate performance metric, how intelligent systems unlock capacity across the healthcare ecosystem, and what types of solutions and founders are best positioned to create outsized value in an era where saved minutes translate to measurable impact.

Hosted by Plug And Play

• Osama Alsaleh, Head of Health Partnerships, Plug and Play Tech Center

• Community Impact Award — Recognizing leaders improving community health outcomes, advancing health equity, or elevating patient voices.
• Breakthrough Startup Award — Highlighting startups demonstrating meaningful impact, validated traction, and a clear path toward scale.

A keynote conversation with a leading pharma executive exploring the scientific and technological advances transforming cancer therapy. From precision medicines and new treatment modalities to platform-based innovation and rapid development pathways, this session examines how the next era of oncology therapeutics is improving speed, specificity, and impact for patients worldwide.

• Sunil Verma, SVP Global Head, Oncology Franchise, AstraZeneca

Oncology trials are evolving rapidly as AI, real-world data, and intelligent workflow automation reshape how therapies move from discovery to patients. This multi-stakeholder panel—featuring leaders from health systems, pioneering startups, and forward-looking investors—will explore how next-generation trial infrastructure accelerates time-to-market by improving protocol design, identifying the right patients earlier, and reducing operational friction across sites. Panelists will discuss what it takes to build a system where the right patient gets the right drug at the right moment—and how these advances ultimately expand access, increase trial diversity, and bring lifesaving therapies to patients faster.

• Anil Saldanha, Chief Innovation Officer, Rush University Medical Center
• Sebastien Rhodes, VP Strategy and Operations, Triomics

Even the most advanced oncology therapies struggle to reach the patients who need them due to fragmented workflows, access barriers, logistical delays, and limited visibility into real-world eligibility. This panel brings together leaders from health systems and payers to examine how AI and digital innovation can bridge the commercial adoption gap—ensuring that breakthrough therapies don’t stall after approval.

• Rasu Shrestha MD, MBA, EVP & Chief Innovation & Commercialization Officer, Advocate Health
• Omid Toloui, Vice President, Innovation, Elevance Health
• Philippe Spiess, MD, Professor of Genitourinary Oncology, Moffitt Cancer Center

Innovation in oncology is expanding well beyond artificial intelligence. This panel explores how wearable technologies, advanced sensors, remote monitoring tools, and other emerging solutions are reshaping cancer detection, treatment, and ongoing care. Speakers will discuss how these technologies generate real-time insights, extend care beyond the clinic, and enable more personalized and proactive cancer management. Learn how health systems and innovators are integrating wearables and next-generation tools into pathways that support earlier intervention, improved patient experience, and better outcomes across the oncology journey.

• Ryan McGinnis, PhD, Founding Director, Center for Remote Health Monitoring, Wake Forest University Center for Remote Health Monitoring

Environmental toxins, unsafe food additives, and pervasive pollutants contribute to rising cancer incidence—representing a largely untapped frontier for innovation. This session explores how technology (“code”) and investment (“capital”) can drive systemic prevention by improving air, water, and food systems. With federal momentum toward eliminating carcinogenic exposures and growing consumer demand for transparency, panelists will discuss how prevention can become a scalable, market-driven opportunity that reduces long-term cancer burden.

• David Callaway, Chief, Crisis Operations & Sustainability, Atrium Health

Join us for an open-to-all networking reception where attendees can meet peers, engage with our partners, and explore the broader ecosystem driving innovation in oncology. Enjoy light hors d’oeuvres and drinks as you connect with leaders across health systems, industry, startups, and investment.

During the reception, we will also announce the CancerX Accelerator Showcase winners, following the startup pitches earlier in the day. Celebrate the new cohort, build meaningful relationships, and discover opportunities to collaborate across the CancerX community.